Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/WA/Olympia
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Olympia, WA

Studies commonly pay $75 to $4,500 per completed study

229 clinical trials are currently recruiting participants within 30 miles of Olympia. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

229studies recruiting
5+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Olympia right now

Top 25 of 229 recruiting studies, sorted by proximity — each links to its official registry page

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

Locally Advanced Head and Neck Squamous Cell Carcinoma Phase 3 Interventional 1,145 participants sought
Research Site — Tacoma, Washington (25.8 mi) · Sponsor: AstraZeneca

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Breast Cancer Phase 3 Interventional 450 participants sought
Northwest Medical Specialties — Tacoma, Washington (25.8 mi) · Sponsor: Hoffmann-La Roche

CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms

Traumatic Brain Injury, Insomnia N/A Interventional 360 participants sought
Madigan Army Medical Center — Fort Lewis, Washington (14.8 mi) · Sponsor: Johns Hopkins University

The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System

Chronic Pain, Musculoskeletal Pain N/A Interventional 608 participants sought
Madigan Army Medical Center — Tacoma, Washington (25.8 mi) · Sponsor: Brooke Army Medical Center

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Breast Neoplasms, Triple Negative Breast Neoplasms Phase 3 Interventional 2,400 participants sought
Northwest Medical Specialties, PLLC ( Site 0067) — Tacoma, Washington (25.8 mi) · Sponsor: Merck Sharp & Dohme LLC

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
Multicare Health System — Tacoma, Washington (25.8 mi) · Sponsor: Novo Nordisk A/S

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought
Northwest Medical Specialties — Tacoma, Washington (25.8 mi) · Sponsor: Hoffmann-La Roche

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Colitis, Ulcerative Phase 3 Interventional 882 participants sought
GI Alliance Tacoma — Tacoma, Washington (25.8 mi) · Sponsor: Janssen Research & Development, LLC

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: National Cancer Institute (NCI)

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Childhood Medulloblastoma Phase 3 Interventional 225 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: Children's Oncology Group

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: NRG Oncology

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic Phase 3 Interventional 735 participants sought
Vista Oncology ( Site 5449) — Olympia, Washington (0.4 mi) · Sponsor: Merck Sharp & Dohme LLC

Function After Anterior Cervical Discectomy and Fusion Surgery: Timing of Physical Therapy

Cervical Spine Degeneration, ACDF Surgery N/A Interventional 76 participants sought
Madigan Army Medical Center — Tacoma, Washington (25.8 mi) · Sponsor: Vanderbilt University Medical Center

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Hypothyroidism Phase 2, Phase 3 Interventional 2,800 participants sought
MultiCare Institute for Research & Innovation /ID# 255954 — Tacoma, Washington (25.8 mi) · Sponsor: AbbVie

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Phase 3 Interventional 247 participants sought
Providence Regional Cancer System-Lacey — Lacey, Washington (3.5 mi) · Sponsor: National Cancer Institute (NCI)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought
Mary Bridge Children's Hospital and Health Center — Tacoma, Washington (25.8 mi) · Sponsor: PedAL BCU, LLC

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 3 Interventional 380 participants sought
Northwest Medical Specialties Tacoma /ID# 276281 — Tacoma, Washington (25.8 mi) · Sponsor: AbbVie

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

Lung Carcinoma N/A Interventional 237 participants sought
South Puget Intertribal Planning Agency (SPIPA) — Shelton, Washington (15.4 mi) · Sponsor: Fred Hutchinson Cancer Center

Investigating Medical Massage Therapy for Patients With Sub-Acute Lower Back Pain

Lower Back Pain, Subacute Lower Back Pain N/A Interventional 220 participants sought
Madigan Army Medical Center — Joint Base Lewis McChord, Washington (15.7 mi) · Sponsor: The Geneva Foundation

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Paroxysmal Atrial Fibrillation N/A Observational 250 participants sought
Franciscan Heart and Vascular Associates — Tacoma, Washington (25.8 mi) · Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease Phase 2, Phase 3 Interventional 1,092 participants sought
GI Alliance Tacoma — Tacoma, Washington (25.8 mi) · Sponsor: Janssen Research & Development, LLC

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis Phase 3 Interventional 762 participants sought
89bio Clinical Study Site — Tacoma, Washington (25.8 mi) · Sponsor: 89bio, Inc.
Actively enrolling

Studies you may be able to join near Olympia

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Olympia

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Vantage Clinical Research Group

3703 Ensign Rd NE #10A, Olympia, WA 98506
(360) 459-5515

Northwest Clinical Research Center

★ 3.9
1951 152nd Pl NE #200, Bellevue, WA 98007
(425) 453-0404
"Great staff and awesome research studies."
— Linda Martinez, 5★

Providence Regional Cancer System - Lacey

★ 4.4 (23 reviews)
4525 3rd Ave SE #200, Lacey, WA 98503
(360) 754-3934
"Would be a 5, but all the healthy workers taking ALL the parking spots surrounding the handicap spots. There are more than 10 handicapped patients th…"
— Fraser Mack, 3★

Rainier Clinical Research Center

★ 4.3
800 SW 39th St Ste 110, Renton, WA 98057
(425) 251-1720
"I have been participating in Type 1 Diabetes studies at Rainier Clinical for at least 15 years and until recently have been impressed with the manage…"
— Annalise k, 3★

Seattle Clinical Research Center

★ 5.0
633 Yesler Wy, Seattle, WA 98104
(206) 522-3330
"I have been part of a vaccine trial here and the staff are so kind. I have a lot of medical anxiety due to some poor experiences. Typically, being in…"
— Kamla Anand Corder, 5★

Clinical trials in Olympia: what's recruiting

The Olympia area currently has 229 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Olympia, the most active research areas are:

  • Cancer & Oncology13 studies
  • Brain & Mental Health2 studies
  • Immune & Skin2 studies
  • Heart & Vascular1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Olympia, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Olympia

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Olympia participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Olympia pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Olympia, WA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Olympia?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Olympia?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Olympia.

Paid clinical trials near Olympia

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of WA

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts